These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 16944277

  • 1. Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study.
    Lindblom N, Kivinen S, Heiskala H, Laakso ML, Kaski M.
    J Inherit Metab Dis; 2006 Oct; 29(5):637-46. PubMed ID: 16944277
    [Abstract] [Full Text] [Related]

  • 2. Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.
    Arvio P, Arvio M, Kero M, Pirinen S, Lukinmaa PL.
    J Med Genet; 1999 May; 36(5):398-404. PubMed ID: 10353787
    [Abstract] [Full Text] [Related]

  • 3. Aspartylglucosaminuria among Palestinian Arabs.
    Zlotogora J, Ben-Neriah Z, Abu-Libdeh BY, Sury V, Zeigler M.
    J Inherit Metab Dis; 1997 Nov; 20(6):799-802. PubMed ID: 9427148
    [Abstract] [Full Text] [Related]

  • 4. Disturbed metabolism of copper and zinc in aspartylglycosaminuria: possible involvement with connective tissue changes.
    Näntö-Salonen K, Halme T, Penttinen R, Langevelde FV, Vis RD, Alfthan G.
    J Inherit Metab Dis; 1985 Nov; 8(4):212-8. PubMed ID: 3939546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.
    Autti T, Lönnqvist T, Joensuu R.
    Acta Radiol; 2008 Jul; 49(6):687-92. PubMed ID: 18568562
    [Abstract] [Full Text] [Related]

  • 10. Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
    Ikonen E, Peltonen L.
    Hum Mutat; 1992 Jul; 1(5):361-5. PubMed ID: 1301945
    [Abstract] [Full Text] [Related]

  • 11. Dissection of the molecular pathology of aspartylglucosaminuria provides the basis for DNA diagnostics and future therapeutic interventions.
    Ikonen E, Syvänen AC, Peltonen L.
    Scand J Clin Lab Invest Suppl; 1993 Jul; 213():19-27. PubMed ID: 8322015
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aspartylglycosaminuria: a review.
    Arvio M, Mononen I.
    Orphanet J Rare Dis; 2016 Dec 01; 11(1):162. PubMed ID: 27906067
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chronic arthritis in patients with aspartylglucosaminuria.
    Arvio MA, Rapola JM, Pelkonen PM.
    J Rheumatol; 1998 Jun 01; 25(6):1131-4. PubMed ID: 9632076
    [Abstract] [Full Text] [Related]

  • 17. Aspartylglucosaminuria in the United States.
    Hreidarsson S, Thomas GH, Valle DL, Stevenson RE, Taylor H, McCarty J, Coker SB, Green WR.
    Clin Genet; 1983 Jun 01; 23(6):427-35. PubMed ID: 6883788
    [Abstract] [Full Text] [Related]

  • 18. Deletion of exon 8 causes glycosylasparaginase deficiency in an African American aspartylglucosaminuria (AGU) patient.
    Fisher KJ, Aronson NN.
    FEBS Lett; 1991 Aug 19; 288(1-2):173-8. PubMed ID: 1879549
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epileptic seizures in aspartylglucosaminuria: a common disorder.
    Arvio M, Oksanen V, Autio S, Gaily E, Sainio K.
    Acta Neurol Scand; 1993 May 19; 87(5):342-4. PubMed ID: 8333236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.